This website provides information about laboratory diagnostic services. The analyses presented are not a therapy and do not replace medical diagnosis and treatment. Medical decisions are made exclusively by your attending physician.

Discover the highlights of our scientific tumor lectures/ tumor training lectures or tumor lectures congress from the successful Cancer Diagnostics Medical Congress in May 2025, ! The scientific cancer lectures / scientific oncology lectures of our international experts have set new standards in tumor medicine.

Our tumor lectures congress covered the latest research findings and innovative diagnostic procedures. The scientific oncology lectures showed impressive progress in personalized tumour medicine. This cancer lectures congress documentation summarizes the most important findings.

The tumor training lectures at our congress inspired over 500 oncology professionals. Each expert lecture on tumor diagnostics brought new insights for daily practice. Our scientific tumor presentations and cancer education lectures offer you valuable content to read up on .

Review of the Therapist Congress 2026 of iQMedix GmbH

Advanced training at the highest level

New insights, inspiring encounters and impulses for your practice

Our Therapeutics Congress took place on March 21, 2026 – and it was an extraordinary day. With over 70 participants, we doubled the number of visitors compared to 2025 – a strong signal of the growing importance of molecular oncological diagnostics and personalized therapy.

Renowned experts from science, clinics and practice gave seven presentations on the latest findings and developments in modern oncology.

The topics of the day

The path of your sample through our laboratory

Dr. Daniel Heylmann, Senior Scientist at iQMedix, took the participants behind the scenes: How does a sample pass through our laboratory – from arrival to findings? A transparent insight into processes that form the basis of every personalized therapy decision.

Better vitamin D3 uptake for cancer therapy

Dr. Alexander Michalzik, founder of Biotikon and head of a naturopathic practice for integrative homeopathy, showed how the bioavailability of vitamin D3 can be optimized – and the specific significance of this for cancer patients.

Newer oncological therapies

Dr. Reiner Hubert Steffan, Managing Director and Chief Scientist at iQMedix, gave a well-founded overview of current developments in oncology – with a focus on approaches that are becoming increasingly important in modern oncology.

DNA repair in senescence and cancer therapy

Prof. Dr. Bernd Kaina from the Institute of Toxicology at the Mainz University Medical Center devoted himself to a fascinating field of research: What role do DNA repair mechanisms play in the development and treatment of cancer – and how does cellular senescence influence this process?

Minimally invasive therapies in modern oncology - a well-kept secret

Prof. Dr. med. Attila Kovács, Chief Physician for Diagnostic and Interventional Radiology at the Wege Clinic in Bonn, presented modern minimally invasive procedures in oncology – methods which, despite their effectiveness, still receive too little attention in public discourse.

Nutrition as the foundation of cancer therapy

Prof. Dr. Roland Hennes, Medical Director at SUN AG, made it clear that nutrition is not a marginal issue, but a central component of any oncological therapy. His presentation showed how nutritional strategies are increasingly being discussed as an integral part of oncological care.

Vitamins for cancer: benefit or harm?

Dr. Reinhard Becker, MD, Managing Director of iQMedix, concluded the day of lectures with one of the most discussed questions in integrative oncology – and provided a differentiated, evidence-based answer as to when vitamins help and when caution is advised.

Delve deeper into the topics

We will soon be providing further content and information on selected presentations here on our website. Please check back regularly – we will be adding to the articles on an ongoing basis.

We look forward to continuing our discussions with you – and to the next congress in 2027.

Tumor Lectures Congress – Innovative Research Results

The tumor lectures congress of our event presented groundbreaking developments in molecular tumor diagnostics. Our krebs vorträge kongress highlighted new biomarkers and their clinical application. The tumor lectures congress impressively demonstrated the future of personalized tumor medicine.

Scientific oncology lectures – International expertise

The scientific oncology lectures were given by world-renowned tumor researchers and clinicians. Our scientific tumor presentations covered all relevant areas of modern oncology. The scientific oncology lectures offered participants unique insights into current tumor research projects.

Tumor Training Lectures – Practice-relevant training

The tumor training lectures successfully combined scientific findings with practical application. Our cancer training lectures showed directly implementable improvements for patient care. With tumor fortbildung vorträge, participants received valuable CME points and practical knowledge.

Expert lecture on tumor diagnostics – Groundbreaking presentations

Each expertenvortrag tumordiagnostik presentation was given by leading specialists in international tumor medicine. The expertenvortrag krebsdiagnostik presentations covered cutting-edge technologies and methods. These expertenvortrag tumordiagnostik sessions set new standards for cancer diagnostics education.

Thanks for the feedback

On behalf of the entire team and all of this year's speakers, we would like to thank you for your valuable feedback

I attended the iQMedix Therapy Congress on 21.03.2026 and it was a very valuable event. The presentations were not only very informative, but also excellently put together. You could clearly feel how much care and commitment went into the selection of topics and speakers. I particularly liked the successful mix of current scientific findings and practical impulses for everyday practice. I was able to take a lot of the content directly with me and reflect on it - that's what makes a really good congress for me. The pleasant atmosphere and great organization also rounded off the day. There was plenty of room for exchange, new contacts and inspiring discussions. A big thank you to the entire team for this successful event and I would love to come back!

Rated 5 out of 5

So informative, friendly and competent. Thank you for so much knowledge sharing and scientific networking!

Rated 5 out of 5

Conclusion

A congress that moves

The iQMedix GmbH Therapists’ Congress 2026 once again demonstrated the power of direct exchange between experts. Well-founded lectures, lively discussions and pioneering approaches in tumor diagnostics and therapy enriched the participants and provided new impetus for daily practice. Recognized as certified further training, the participating doctors were also able to acquire 10 CME points. The consistently positive feedback confirms this: This event is an essential date in the calendar of medical professionals. We look forward to welcoming you again in 2027 – make a note of our next congress now.

Ready for personalized diagnostics?

Personalized diagnostics makes it possible to comprehensively analyse relevant tumour activities regardless of the type of cancer. The knowledge gained forms the basis for individual complementary therapy considerations – tailored to the respective stage of the disease and oriented towards the gentlest possible treatment path.

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

Runs a full panel of 34 gene expressions+ gene expressions and analyzes which natural substances or off-label drugs will dampen the over-expressed genes.

liquid biopsy krebs

iCOMPLETE

The blood test for comprehensive analysis of your tumor activity.

Runs a full panel of 85+ gene expressions and analyzes which approved drugs, including chemotherapeutics, targeted drugs and immunotherapies, as well as natural compounds or off-label drugs, will dampen the overexpressed genes.

Your knowledge advantage starts here:

Contact us at any time

CONTACT FORM DOCTOR

We take the time for you

Contact us at any time

CONTACT FORM PATIENT

We take the time for you

Sie fragen, wir antworten

Haben Sie Fragen? Hier finden Sie ANtworten!

Was ist die Testung genetischer Expressionswerte von Krebszellen?

Durch molekularbiologische Analyse identifizieren wir das individuelle Aktionsprofil eines Tumors und finden die therapeutischen Angriffspunkte.

Die Messung der RNA-Genexpressionswerte ist dem Tumorgeschehen näher als eine reine Mutationsanalyse. Mit dieser Messung kann man für wichtige Signalwege des Tumors das konkrete und aktuelle Aktionsprofil und deren Eigenschaften ermitteln.

Per Flüssigbiopsie ist eine Gewinnung frischer lebender Tumorzellen einfach und schmerzfrei möglich.  

Es werden auch Tumorzellen aus Körperregionen gewonnen, die wie in Lunge, Bauchspeicheldrüsen oder Gehirn für herkömmliche Gewebebiopsien oft nur schwierig zu erreichen sind.

Man kann weiterhin auch Tumorzellen aus Urin, Aszites oder Liquor erhalten.

Wenn Gewebebiopsate vorliegen, kann man auch diese nutzen. Somit sind vielfältige Möglichkeiten gegeben, um Tumorzellen zu gewinnen.

Die iSelect und iComplete Tests liefern entscheidende Erkenntnisse bezüglich:

• der Aggressivität des Tumors

• der Manipulation des Immunsystems durch den Tumor

• der Resistenzen gegenüber Medikamenten

• der Aktivität relevanter Signale

• der Wirksamkeit bestimmter Substanzen

Die Messergebnisse werden therapeutischen Substanzen zugeordnet, basierend auf anerkannten Studien, sodass der behandelnde Arzt Optionen für eine gezielte Therapie erhält.

Üblicherweise werden die Tumorzellen aus einer Blutprobe extrahiert, gefolgt von der Analyse der RNA, um die Aktivität von Genen zu bestimmen. Die Tumorzellen können aber auch aus einer Biopsie, Liquor oder Aszites entnommen werden.

Die mit dem iSelect oder iComplete Test gewonnen Therapieoptionen zeigen personalisierte und für den individuellen Tumor zielgerichtete Therapieoptionen auf, die der Therapeut umsetzen kann. Weiterhin werden auch individuell für den vorliegenden Tumor ungeeignete Substanzen die z.B. in der Chemotherapie eingesetzt werden, aufgezeigt. Damit kann man z.B. stark toxische Therapeutika, die der Tumor einfach durchschleust, identifizieren und für die Therapie ausschließen.

Bitte sprechen Sie uns über die kostenlose Beratung an, damit wir den richtigen Test herausfinden und Ihnen die damit verbundenen Kosten mitteilen können.

Die Laborarbeit dauert ca. 10 Arbeitstage. Danach wird ein Bericht geschrieben, der je nach Komplexität des Falles ca. 1 – 3 Arbeitstage dauern kann. Der Bericht muss wegen gesetzlicher Vorgaben im Falle von Krebs an den behandelnden Arzt gehen. Er kann dann den Bericht an den Patienten weiterleiten.

Die Zuverlässigkeit hängt von verschiedenen Faktoren ab, einschließlich der Testmethode und der Qualität der genommenen Probe. In vielen Fällen sind Liquid Biopsy-Tests jedoch eine zuverlässige Ergänzung zu anderen Diagnosemethoden.

1

Contact us and order the blood collection kit for your doctor

Give us a call or send us a message. We will advise you on our tests. We will send the corresponding blood collection kit to your doctor free of charge.

2

Make an appointment for a blood test with your doctor

The blood sample is taken by a doctor you trust or a doctor in our network. Important for chemotherapy patients: Schedule this appointment at the earliest 10-14 days after your last chemotherapy.

3

Take the blood collection kit with you to your doctor's appointment

Bring the blood collection kit you received from us to your doctor’s appointment. After the blood sample has been taken, it will be collected by our courier service and transported to our laboratory.

4

HAVE YOUR DOCTOR COMPLETE THE DOCUMENTS, SIGN THE ORDER and return them to us

  • Check that the enclosed documents are complete
  • Have the doctor complete the order for molecular diagnostics with your consent and signature
  • Complete the enclosed medication plan
  • Enclose copies of your clinic reports/anamnesis
  • Please sign all forms and return the originals to us

5

Your doctor or you:
Inform us about your blood collection appointment

Please let us know when and where the sample is to be collected by e-mail or telephone at least one day before the scheduled blood collection. We need the location, date and a time window of 2 hours for our courier service.

This is the only way we can organize the collection of the sample from your practice.

6

Discuss the results with your doctor

The report is prepared within approx. 10-15 working days after receipt of payment from the patient, depending on the case.

Arrange a consultation with your doctor to discuss the test results. We will send the test report directly to your doctor.

Kontaktieren Sie uns zu jeder Zeit

Wir nehmen uns die zeit für Sie

We wish you a pleasant journey

Contact us at any time

CONTACT FORM DOCTOR

We take the time for you

Contact us at any time

CONTACT FORM PATIENT

We take the time for you

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

Tumors release cancer cells into the blood (circulating tumor cells – CTC) at a very early stage. If these cells settle elsewhere in the body, they develop into metastases. iPREVENT often detects circulating tumor cells in the blood at a very early stage, when imaging methods (ultrasound, CT, MRI) do not yet show anything.

If a large number of such cells are found, the iSelect or iComplete test can be connected.
This means that tumors can usually be detected at an early stage and treated appropriately. Early treatment usually significantly increases success and the chances of survival. The gentler treatment options in the early stages also mean that significantly fewer side effects can be expected.

THE iPREVENT TEST OFFERS DECISIVE ADVANTAGES:

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

The iSELECT test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.
The advantage of the iSELECT test is that it captures a picture of over 85 features of a tumour, regardless of the type of cancer, and thus generates a personalized activity profile of the tumour for the patient. Recognized first-class studies are then used to identify targeted therapy options with complementary substances (plant substances and off-label drugs). Tailored to the early stages of the disease, individual therapy approaches are obtained that are both as effective as possible and have as few side effects as possible.

The iSelect test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it. For example, excessive BCL2 expression can indicate that natural cell death in the tumor is being prevented and that treatment with e.g. plant substances and off-label drugs is a possible therapeutic option.

Based on scientific studies, the iSELECT test assigns complementary drugs (natural substances or off-label drugs) to the individual activity profile of the tumor, which can compensate for the misdirected activity. The results of the test are presented in an easy-to-understand, detailed report.

During the course of the disease, the test is used to obtain information about changes in signal and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iSELECT TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all complementary therapy options available to your medical team for your treatment according to the gene expression analysis.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

liquid biopsy krebs

iCOMPLETE

The blood test for a comprehensive analysis of your tumor's activity and the widest possible range of treatment options

The iComplete test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.

The advantage of the iComplete test is that, regardless of the type of cancer, a complete picture of the particularly relevant activities of a tumour is recorded and thus personalized and targeted therapy options are identified for the patient. Depending on the stage of the disease, individual treatment options are provided that are both as effective as possible and have as few side effects as possible.

The iComplete test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it.

Based on scientific studies, the iComplete test analyzes which approved drugs, including chemotherapeutics, targeted drugs and immunotherapies as well as natural substances or off-label drugs can affect the signaling pathways or metabolic pathways. The results of the test are presented in an easy-to-understand detailed report.

During the course of the disease, the test is used to obtain information about changes in signal and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iCOMPLETE TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all conventional and complementary therapy options that the gene expression analysis considers particularly promising and that your medical team can then implement.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

tumor diagnostics cancer

iPREVENT

The blood test for early detection or monitoring of cancer

Tumors release cancer cells into the blood (circulating tumor cells – CTC) at a very early stage. If these cells settle elsewhere in the body, they develop into metastases. iPREVENT often detects circulating tumor cells in the blood at a very early stage, when imaging methods (ultrasound, CT, MRI) do not yet show anything.

If a large number of such cells are found, the iSelect or iComplete test can be connected.
This means that tumors can usually be detected at an early stage and treated appropriately. Early treatment usually significantly increases success and the chances of survival. The gentler treatment options in the early stages also mean that significantly fewer side effects can be expected.

THE iPREVENT TEST OFFERS DECISIVE ADVANTAGES:

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

cancer diagnostics

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

The iSELECT test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.
The advantage of the iSELECT test is that it captures a picture of over 85 features of a tumour, regardless of the type of cancer, and thus generates a personalized activity profile of the tumour for the patient. Recognized first-class studies are then used to identify targeted therapy options with complementary substances (plant substances and off-label drugs). Tailored to the early stages of the disease, individual therapy approaches are obtained that are both as effective as possible and have as few side effects as possible.

The iSelect test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it. For example, excessive BCL2 expression can indicate that natural cell death in the tumor is being prevented and that treatment with e.g. plant substances and off-label drugs is a possible therapeutic option.

Based on scientific studies, the iSELECT test assigns complementary drugs (natural substances or off-label drugs) to the individual activity profile of the tumor, which can compensate for the misdirected activity. The results of the test are presented in an easy-to-understand, detailed report.

During the course of the disease, the test is used to obtain information about changes in signal and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iSELECT TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all complementary therapy options available to your medical team for your treatment according to the gene expression analysis.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

liquid biopsy krebs

iCOMPLETE

The blood test for a comprehensive analysis of your tumor's activity and the widest possible range of treatment options

The iComplete test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.

The advantage of the iComplete test is that, regardless of the type of cancer, a complete picture of the particularly relevant activities of a tumour is recorded and thus personalized and targeted therapy options are identified for the patient. Depending on the stage of the disease, individual treatment options are provided that are both as effective as possible and have as few side effects as possible.

The iComplete test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it.

Based on scientific studies, the iComplete test analyzes which approved drugs, including chemotherapeutics, targeted drugs and immunotherapies as well as natural substances or off-label drugs can affect the signaling pathways or metabolic pathways. The results of the test are presented in an easy-to-understand detailed report.

During the course of the disease, the test is used to obtain information about changes in signal and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iCOMPLETE TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all conventional and complementary therapy options that the gene expression analysis considers particularly promising and that your medical team can then implement.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

CONTACT FORM PATIENT

We take the time for you

We wish you a pleasant journey